BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38105682)

  • 21. Upregulated tumor sirtuin 2 expression correlates with reduced TNM stage and better overall survival in surgical breast cancer patients.
    Shi P; Zhou M; Yang Y
    Ir J Med Sci; 2020 Feb; 189(1):83-89. PubMed ID: 31418154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modification of the AJCC/UICC 8th edition staging system for intrahepatic cholangiocarcinoma: proposal for an alternative staging system from cholangiocarcinoma-prevalent Northeast Thailand.
    Sa-Ngiamwibool P; Aphivatanasiri C; Sangkhamanon S; Intarawichian P; Kunprom W; Thanee M; Prajumwongs P; Loilome W; Khuntikeo N; Titapun A; Jareanrat A; Thanasukarn V; Srisuk T; Luvira V; Eurboonyanun K; Promsorn J; Wee A; Koonmee S
    HPB (Oxford); 2022 Nov; 24(11):1944-1956. PubMed ID: 35810105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment and validation of a prognostic nomogram for patients with resectable perihilar cholangiocarcinoma.
    Chen P; Li B; Zhu Y; Chen W; Liu X; Li M; Duan X; Yi B; Wang J; Liu C; Luo X; Li X; Li J; Liang L; Yin X; Wang H; Jiang X
    Oncotarget; 2016 Jun; 7(24):37319-37330. PubMed ID: 27144432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel prognostic biomarker for cholangiocarcinoma: circRNA Cdr1as.
    Jiang XM; Li ZL; Li JL; Xu Y; Leng KM; Cui YF; Sun DJ
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):365-371. PubMed ID: 29424892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prediction of prognosis of patients with radical resection of intrahepatic cholangiocarcinoma based on single cell omics].
    Chen JL; Tang Y; Qin DL; Li ZL; Tang ZH; Quan ZW
    Zhonghua Wai Ke Za Zhi; 2024 Apr; 62(4):316-323. PubMed ID: 38432673
    [No Abstract]   [Full Text] [Related]  

  • 26. Survival analysis and prognostic nomogram for patients undergoing resection of extrahepatic cholangiocarcinoma.
    van der Gaag NA; Kloek JJ; de Bakker JK; Musters B; Geskus RB; Busch ORC; Bosma A; Gouma DJ; van Gulik TM
    Ann Oncol; 2012 Oct; 23(10):2642-2649. PubMed ID: 22532585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of postoperative adjuvant transarterial chemoembolization on the prognosis of early-stage intrahepatic cholangiocarcinoma: a single center study.
    Liu G; Guo W; Wang H; Liu W; Lei L; Xie Q; Li X; Zou S; Wang P; Zhou H; Hu H
    Ann Palliat Med; 2021 Apr; 10(4):3673-3683. PubMed ID: 33691434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-resection prognosis of combined hepatocellular carcinoma-cholangiocarcinoma cannot be predicted by the 2019 World Health Organization classification.
    Kim M; Hwang S; Ahn CS; Kim KH; Moon DB; Song GW; Jung DH; Hong SM
    Asian J Surg; 2021 Nov; 44(11):1389-1395. PubMed ID: 33766528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The predictive value of lymphocyte to monocyte ratio for overall survival in cholangiocarcinoma patients with hepatic resection.
    Lv M; Wang K; Zhang Z; Zhang Z; Wan J
    Cancer Med; 2023 Apr; 12(8):9482-9495. PubMed ID: 36825605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum KIAA1199 is an advanced-stage prognostic biomarker and metastatic oncogene in cholangiocarcinoma.
    Zhai X; Wang W; Ma Y; Zeng Y; Dou D; Fan H; Song J; Yu X; Xin D; Du G; Jiang Z; Zhang H; Zhang X; Jin B
    Aging (Albany NY); 2020 Nov; 12(23):23761-23777. PubMed ID: 33197891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive radiomics nomogram for predicting survival of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Tang YY; Zhao YN; Zhang T; Chen ZY; Ma XL
    World J Gastroenterol; 2021 Nov; 27(41):7173-7189. PubMed ID: 34887636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion.
    Zhou Z; Ma J
    Cancer Biomark; 2019; 24(2):173-181. PubMed ID: 30594918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioinformatic analysis the expression and clinical significance of CDRT15 in cholangiocarcinoma using TCGA database.
    Yu T; Zhang T; Zhao L; Li K; Li J; Yu A
    Medicine (Baltimore); 2023 Aug; 102(31):e34602. PubMed ID: 37543771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proposed modification of the eighth edition of the AJCC staging system for intrahepatic cholangiocarcinoma.
    Zhang XF; Xue F; He J; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Lv Y; Pawlik TM
    HPB (Oxford); 2021 Sep; 23(9):1456-1466. PubMed ID: 33814298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prognostic value of a predictive model comprising preoperative inflammatory response and nutritional indexes in patients with gastric cancer].
    Wu LL; Cai MZ; Wang BG; Deng JY; Ke B; Zhang RP; Liang H; Wang XN
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jul; 26(7):680-688. PubMed ID: 37583026
    [No Abstract]   [Full Text] [Related]  

  • 38. The Predictive Value of Staging Systems and Inflammation Scores for Patients with Combined Hepatocellular Cholangiocarcinoma After Surgical Resection: a Retrospective Study.
    He C; Mao Y; Wang J; Song Y; Huang X; Lin X; Li S
    J Gastrointest Surg; 2018 Jul; 22(7):1239-1250. PubMed ID: 29667093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of MUC4 for mass-forming intrahepatic cholangiocarcinoma after hepatectomy.
    Yeh CN; Pang ST; Wu RC; Chen TW; Jan YY; Chen MF
    Oncol Rep; 2009 Jan; 21(1):49-56. PubMed ID: 19082442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel five-lncRNA signature panel improves high-risk survival prediction in patients with cholangiocarcinoma.
    Xie X; Wang Y; Zhang S; Li J; Yu Z; Ding X; Ye L; Gong P; Zhu Q; Li J; Chen Z; Yao X; Du Z; Zeng Q; Chen H; Yang Z; Chen G
    Aging (Albany NY); 2021 Jan; 13(2):2959-2981. PubMed ID: 33472169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.